Free Trial

ASIA: Hong Kong Listed Equities Rally, Mainland Equities Struggle

ASIA

Chinese and Hong Kong equities saw mixed moves today, with AI-related stocks continuing their rally, while pressure mounted on consumer and healthcare sectors. DeepSeek's AI-driven surge remains a key bullish driver, with Morgan Stanley, JPMorgan, and UBS expressing optimism that the rally is far from over. The MSCI China Index has now gained 15% from its January low, supported by increased global investor interest in the nation’s tech sector.

  • Medical equipment stocks surged after Citigroup turned constructive on the sector, citing market share gains from foreign brands and long-term fundamentals. MicroPort MedBot (+8.5%), MicroPort Scientific (+5.7%), and Inkon Life (+7.7%) led the advance, with Citi highlighting potential stimulus measures at next month’s Two Sessions as a further catalyst.
  • Meituan tumbled as much as 6.1% after JD.com announced it would waive annual commissions for new restaurant partners, intensifying competition in the food delivery sector. JD.com shares rose 2%, while Alibaba share surged almost 7%. The HStech Index tracked Alibaba higher, however has since given back about half of the mornings gains to trade 1.30% higher at the break.
  • Key equity benchmarks: HSI is +1.56%, HS Property Index +2.15%, HS China Enterprise Index +1.50% while China Mainland equities underperform with the CSI 300 -0.10%.
  • Overall, sentiment remains strong for AI and tech stocks, while consumer and platform businesses face increasing pressure from competition and regulatory concerns.
220 words

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.

Chinese and Hong Kong equities saw mixed moves today, with AI-related stocks continuing their rally, while pressure mounted on consumer and healthcare sectors. DeepSeek's AI-driven surge remains a key bullish driver, with Morgan Stanley, JPMorgan, and UBS expressing optimism that the rally is far from over. The MSCI China Index has now gained 15% from its January low, supported by increased global investor interest in the nation’s tech sector.

  • Medical equipment stocks surged after Citigroup turned constructive on the sector, citing market share gains from foreign brands and long-term fundamentals. MicroPort MedBot (+8.5%), MicroPort Scientific (+5.7%), and Inkon Life (+7.7%) led the advance, with Citi highlighting potential stimulus measures at next month’s Two Sessions as a further catalyst.
  • Meituan tumbled as much as 6.1% after JD.com announced it would waive annual commissions for new restaurant partners, intensifying competition in the food delivery sector. JD.com shares rose 2%, while Alibaba share surged almost 7%. The HStech Index tracked Alibaba higher, however has since given back about half of the mornings gains to trade 1.30% higher at the break.
  • Key equity benchmarks: HSI is +1.56%, HS Property Index +2.15%, HS China Enterprise Index +1.50% while China Mainland equities underperform with the CSI 300 -0.10%.
  • Overall, sentiment remains strong for AI and tech stocks, while consumer and platform businesses face increasing pressure from competition and regulatory concerns.